May 27, 2026 08:11AM
May 7, 2026 03:23PM
May 6, 2026 08:33AM
Mar 31, 2026 08:55AM
Mar 16, 2026 06:07AM
Feb 3, 2026 06:09AM
Jan 27, 2026 08:45AM Ernexa Therapeutics selected for JETRO Japan acceleration program
Jan 6, 2026 08:15AM
Dec 8, 2025 08:32AM
Oct 29, 2025 08:33AM
Sep 10, 2025 08:30AM
Jul 9, 2025 08:30AM
Jun 24, 2025 08:32AM
Jun 11, 2025 04:36PM Ernexa Therapeutics (ERNA) Files for 57.05M Share Offering by Selling Stockholders
Jun 10, 2025 09:30AM
May 8, 2025 08:30AM
Apr 29, 2025 08:33AM
Mar 25, 2025 08:31AM
Jan 28, 2025 08:31AM
Jan 14, 2025 08:34AM
Dec 3, 2024 08:33AM Eterna Therapeutics (ERNA) Launches Research to Evaluate its Lead Induced Mesenchymal Stem Cell Therapy Candidate’s (ERNA-101) Ability to Induce and Modulate Antitumor Immunity in Ovarian Cancer and
Nov 25, 2024 08:30AM
Nov 14, 2024 08:34AM
Nov 5, 2024 04:33PM
Oct 17, 2024 08:01AM

409,155 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All